ArticleBrain : a journal of neurology2016
CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington's disease.
Lydie Boussicault et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
110 papers cite itlatest 60 shown
this paperpooled ittrialcites it